The milestone comes two months after the company surpassed 500 procedures with the devices, according to a news release. Procedure volume jumped more than 60 percent in the first quarter of 2023 compared to the fourth quarter of 2022.
Prodisc C Vivo and Prodisc C SK were launched in September. Centinel Spine’s Prodisc portfolio has seen more than 225,000 global implantations.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.